Patterns of Failure and Outcome in Patients with Carcinoma of the Anal Margin

Authors: Khanfir, Kaouthar1; Ozsahin, Mahmut2; Bieri, Sabine3; Cavuto, Christiano2; Mirimanoff, René2; Zouhair, Abderrahim2

Source: Annals of Surgical Oncology, Volume 15, Number 4, April 2008 , pp. 1092-1098(7)

Publisher: Springer

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

To evaluate the outcome of patients with carcinoma of anal margin in terms of recurrence, survival, and radiation toxicity.

A series of 45 consecutive patients, with anal margin carcinoma treated between 1983 and 2006 with curative intent at two institutions, was retrospectively analyzed. A surgical excision (close or positive surgical margin in 22 out of 29 patients) was realized before radiotherapy (RT). RT consisted of definitive external beam RT (EBRT) in 36 patients, brachytherapy (BT) alone in two patients, and both BT and EBRT in seven patients. The median total radiation dose was 59.4 Gy (range, 30-74 Gy).

The 5-year locoregional control (LRC) rate was 78% [95% confidence interval (CI), 64-93%]. The 5-year disease-specific survival (DSS) and overall survival (OS) rates were respectively 86% (95% CI, 72-99%) and 55% (95% CI, 44-66%). The overall anal conservation rate was 80% for the whole series. There was no significant association between local recurrence and patient age, histological grade, tumor size, T stage, overall treatment time, RT dose, or chemotherapy. Long-term side effects were observed in 15 patients (33%). Only three patients developed grade 3-4 late toxicity (CTCAE/NCI v3.0). Significant relationship was found between dose, and complication rate (48% for dose ≥59.4 Gy versus 8% for dose < 59.4 Gy; P = 0.03).

We conclude that definitive RT and/or BT yield a good local control and disease-specific survival comparable with published data. This study suggests that radiation dose over 59.4 Gy seems to increase treatment-related morbidity.

Keywords: Anal margin cancer; Radiotherapy; Brachytherapy; Sphincter preservation

Document Type: Research article

DOI: 10.1245/s10434-007-9794-9

Affiliations: 1: Department of Radiation Oncology, Hôpital de Sion, Grand-Champsec 81, CH-1051, Sion, Switzerland, Email: kaouthar.khanfir@rsv-gnw.ch 2: Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland 3: Department of Radiation Oncology, Hôpital de Sion, Grand-Champsec 81, CH-1051, Sion, Switzerland

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$47.00 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A